MyCare - Patients: View your medical records securely online here.
Log in Learn More

Absorb Randomized Controlled Trial – A Clinical Evaluation of Absorb Everolimus Eluting Bioresorbable Vascular Scaffold vs. Xience Drug Eluting Metal Stent in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Description: Compare treatment of lesions (narrowing) in the coronary arteries using bioresorbable stents versus metallic drug-eluting stents. Sponsor: Abbott Vascular.
Active Date: August 22, 2014
Status: Active/Closed to Enrollment
Principal Name: Thomas Stuver, MD
Contact Name: Tia DeRosa, NP
Phone: (585) 922-3536